Table 1.
Compounds | Concentrations (µg mL−1) | ||||
---|---|---|---|---|---|
1 | 10 | 100 | 500 | 1000 | |
4a | 5.39 e * | 5.36 d | 5.01 e | 4.02 c | 1.74 d |
4b | 5.72 d | 5.53 d | 5.29 d | 3.86 d | 2.64 b |
4c | 5.75 d | 5.73 c | 5.65 c | 4.88 b | 2.33 c |
4d | 5.93 d | 5.90 b | 4.92 e | 3.72 d | 1.66 d |
4e | 6.15 c | 6.15 b | 5.27 d | 4.07 c | 1.05 e |
4f | 6.17 c | 6.10 b | 5.97 b | 1.50 g | 0.46 g |
4g | 6.57 b | 6.19 b | 5.63 c | 2.86 f | 0.85 f |
4h | 6.06 c | 6.18 b | 5.64 c | 3.27 e | 1.22 e |
Tebuconazole | 1.83 f | 0.30 e | 0.00 f | 0.00 h | 0.00 h |
Control | 7.14 a | 7.14 a | 7.14 a | 7.14 a | 7.14 a |
* Means followed by the same letter in the column do not differ at 5% probability by the Scott-Knott test.